544
Participants
Start Date
April 27, 2018
Primary Completion Date
September 30, 2020
Study Completion Date
December 3, 2020
TV-46000
TV-46000 will be administered per dose and schedule specified in the arm.
Placebo
Placebo matching to TV-46000 will be administered per schedule specified in the arm.
Teva Investigational Site 59149, Novi Iskar
Teva Investigational Site 59144, Sofia
Teva Investigational Site 59146, Vratsa
Teva Investigational Site 59151, Lovech
Teva Investigational Site 59152, Kazanlak
Teva Investigational Site 59148, Burgas
Teva Investigational Site 59154, Varna
Teva Investigational Site 59150, Varna
Teva Investigational Site 14804, New York
Teva Investigational Site 14800, New York
Teva Investigational Site 14784, New York
Teva Investigational Site 14780, Staten Island
Teva Investigational Site 14772, Cedarhurst
Teva Investigational Site 14789, Allentown
Teva Investigational Site 14775, Scranton
Teva Investigational Site 14793, Thorndale
Teva Investigational Site 14833, Norristown
Teva Investigational Site 14764, Glen Burnie
Teva Investigational Site 14778, Charleston
Teva Investigational Site 14821, Decatur
Teva Investigational Site 14770, Marietta
Teva Investigational Site 14824, Atlanta
Teva Investigational Site 14834, Columbus
Teva Investigational Site 14831, Orange City
Teva Investigational Site 14806, Orlando
Teva Investigational Site 14836, Hallandale
Teva Investigational Site 14787, Hialeah
Teva Investigational Site 14814, Hialeah
Teva Investigational Site 14832, Miami
Teva Investigational Site 14768, Coral Gables
Teva Investigational Site 14783, Coral Gables
Teva Investigational Site 14810, North Miami
Teva Investigational Site 14799, Lauderhill
Teva Investigational Site 14837, Tampa
Teva Investigational Site 14763, Cincinnati
Teva Investigational Site 14782, Dayton
Teva Investigational Site 14798, Saginaw
Teva Investigational Site 14805, Hoffman Estates
Teva Investigational Site 14765, Chicago
Teva Investigational Site 14829, Chicago
Teva Investigational Site 14791, St Louis
Teva Investigational Site 14813, St Louis
Teva Investigational Site 14826, St Louis
Teva Investigational Site 14790, St Louis
Teva Investigational Site 14825, Shreveport
Teva Investigational Site 14769, Little Rock
Teva Investigational Site 14796, Rogers
Teva Investigational Site 14822, Oklahoma City
Teva Investigational Site 14807, Irving
Teva Investigational Site 14781, Dallas
Teva Investigational Site 14766, Dallas
Teva Investigational Site 14801, Houston
Teva Investigational Site 14809, Las Vegas
Teva Investigational Site 14773, Culver City
Teva Investigational Site 14788, Torrance
Teva Investigational Site 14817, La Habra
Teva Investigational Site 14803, Norwalk
Teva Investigational Site 14815, Pico Rivera
Teva Investigational Site 14794, Bellflower
Teva Investigational Site 14823, Long Beach
Teva Investigational Site 14774, Glendale
Teva Investigational Site 14816, Montclair
Teva Investigational Site 14771, Lemon Grove
Teva Investigational Site 14797, Oceanside
Teva Investigational Site 14819, San Marcos
Teva Investigational Site 14818, San Diego
Teva Investigational Site 14828, San Diego
Teva Investigational Site 14776, Colton
Teva Investigational Site 14785, San Bernardino
Teva Investigational Site 14812, Riverside
Teva Investigational Site 14767, Costa Mesa
Teva Investigational Site 14802, Costa Mesa
Teva Investigational Site 14779, Santa Ana
Teva Investigational Site 14811, Anaheim
Teva Investigational Site 14835, Garden Grove
Teva Investigational Site 14777, Orange
Teva Investigational Site 14786, Oakland
Teva Investigational Site 14827, Oceanside
Teva Investigational Site 14820, New Bedford
Teva Investigational Site 14792, Berlin
Teva Investigational Site 14830, Princeton
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY